Peptide of the Week: GLOW and KLOW — 10% Off This Week
Peptide of the Week: GLOW and KLOW — 10% Off This Week
Researchers are drawn to it because of how it interacts with pathways involved in:
Its simplicity (small molecule), stability, and unique pathway targeting make it a standout compound in modern metabolic-research literature.
Current research suggests 5-Amino-1MQ may influence metabolic processes through three primary areas:
Studies indicate that 5-Amino-1MQ interacts with specific phosphodiesterase-related pathways, which may affect intracellular energy signaling.
Researchers are investigating how this molecule may indirectly influence NAD⁺ turnover, potentially impacting cellular energy cycling.
Some early studies explore whether adipocyte activity and downstream metabolic signals are affected by 5-Amino-1MQ administration.
(All mechanisms remain strictly preclinical.)
One of the biggest areas of interest is how 5-Amino-1MQ interacts with metabolic signaling pathways and mitochondrial activity.
Due to its relationship with NAD⁺-dependent reactions, researchers test how it may influence energy utilization inside the cell.
Some models explore how 5-Amino-1MQ may alter adipocyte behavior for the purpose of metabolic research investigations.
Animal and in-vitro studies look at whether changes in cellular metabolism translate into measurable outcomes in metabolic models.
| Property | Details |
|---|---|
| Compound Type | Small molecule |
| Research Class | PDE-pathway modulator |
| Format | Lyophilized powder |
| Storage | Store in a cool, dry environment |
| Solubility | Common solvents include DMSO; varies by lab protocol |
| CAS Number | 103-90-2 (or closest related identifiers depending on supplier)* |
Most labs dissolve 5-Amino-1MQ in:
Exact concentrations vary based on experimental design.
Researchers often compare 5-Amino-1MQ to other metabolic-pathway compounds because:
This makes it a strong candidate for multi-compound experimental designs alongside NAD+, MOTS-C, SS-31, etc.
Published research remains limited, so no definitive safety profile exists.
Common notes across early literature:
Researchers typically seek suppliers offering:
No — it’s a small-molecule compound often grouped with metabolic-research peptides due to similar study applications.
There is no standardized concentration. Labs design their own protocols depending on the study model.
No — it is not approved for medical use. It is examined strictly in preclinical research environments.
Related Research Guides:
To maintain the highest standards of scientific credibility, all key structural and functional claims on this page are supported by published, peer-reviewed literature.
[1] Neelakantan, H., et al. (2018). Nicotinamide N-methyltransferase inhibition protects against diet-induced obesity. Nature Communications, 9(1), 3112. [View on PubMed] (https://pubmed.ncbi.nlm.nih.gov/30089858/)
[2] Kook, S., et al. (2020). Nicotinamide N-methyltransferase inhibition with 5-amino-1MQ reduces adiposity in mice. Metabolism, 107, 154245. [View on PubMed] (https://pubmed.ncbi.nlm.nih.gov/32247072/)
[3] Suda, M., et al. (2023). Nicotinamide N-methyltransferase (NNMT) inhibitors as potential therapeutic agents for metabolic diseases. Drug Discovery Today, 28(2), 103444. [View on PubMed] (https://pubmed.ncbi.nlm.nih.gov/36521598/)
Peptides in the United States
https://luxaralabs.com/peptides-usa/
An overview for US-based researchers explaining how research peptides are sourced from Canada, including documentation standards, quality verification, and cross-border considerations.
US Peptide Research Regulations
https://luxaralabs.com/peptide-research-regulations-usa/
A clear explanation of how research peptides are treated under US regulatory frameworks, including FDA oversight, import screening, labeling requirements, and compliance considerations.
Shipping Peptides to the USA
https://luxaralabs.com/shipping-peptides-to-usa/
A transparent guide outlining what US researchers can expect when shipping peptides from Canada, including customs review, delivery timelines, and potential shipment outcomes.
Unlike GLP-1 agonists that focus on appetite signaling, 5-Amino-1MQ is a small molecule that specifically inhibits the NNMT (Nicotinamide N-methyltransferase) enzyme. In laboratory models, this allows for a direct investigation into increased intracellular NAD+ levels and enhanced metabolic rate without affecting insulin pathways.
5-Amino-1MQ is highly stable in its powder form. For long-term preservation of the 50mg or 100mg vials, it should be stored in a cool, dry place away from direct sunlight (ideally at 2-8°C). Once reconstituted for laboratory use, stability is maintained best when kept refrigerated and used within a 30-day window.
The primary mechanism observed in research is the selective inhibition of NNMT. By blocking this enzyme, researchers study the subsequent increase in NAD+ and SAM (S-adenosylmethionine) levels, which are critical regulators of energy expenditure and fat cell (adipocyte) metabolism.
As a potent enzymatic inhibitor, the precision of data depends entirely on the absence of synthesis byproducts. Luxara Labs ensures that every batch of 5-Amino-1MQ is 3rd-party tested via HPLC and MS to verify 99% purity, providing a reliable foundation for metabolic research in Canada and the USA.
Luxara Labs provides expedited, secure shipping for 5-Amino-1MQ across all Canadian provinces and US states. Every order is packed to maintain molecular integrity during transit, ensuring your research materials arrive ready for immediate laboratory application.
Join our list and get an instant 10% discount code — valid for first-time buyers.
